Van den Abbeele, A. D., Gatsonis, C., de Vries, D. J., Melenevsky, Y., Szot-Barnes, A., Yap, J. T., . . . Siegel, B. A. (2012). ACRIN 6665/RTOG 0132 Phase II Trial of Neoadjuvant Imatinib Mesylate for Operable Malignant Gastrointestinal Stromal Tumor: Monitoring with (18)F-FDG PET and Correlation with Genotype and GLUT4 Expression.
Citação norma ChicagoVan den Abbeele, Annick D., et al. ACRIN 6665/RTOG 0132 Phase II Trial of Neoadjuvant Imatinib Mesylate for Operable Malignant Gastrointestinal Stromal Tumor: Monitoring With (18)F-FDG PET and Correlation With Genotype and GLUT4 Expression. 2012.
Citação norma MLAVan den Abbeele, Annick D., et al. ACRIN 6665/RTOG 0132 Phase II Trial of Neoadjuvant Imatinib Mesylate for Operable Malignant Gastrointestinal Stromal Tumor: Monitoring With (18)F-FDG PET and Correlation With Genotype and GLUT4 Expression. 2012.